Idiopathic thrombocytopenic purpura in childhood: Twenty years of experience in a single center

Pediatrics International

Volumn 54, Issue 4, 2012, Pages 524-527

  Stiakaki, Eftichia ^a   Perdikogianni, Chryssoula ^a   Thomou, Christina ^a   Markaki, Erasmia Athina ^a   Katzilakis, Nikolaos ^a   Tsirigotaki, Maria ^a   Kalmanti, Maria ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

anti CD20 monoclonal antibody; anti D immunoglobulin; children; thrombocytopenia; treatment

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE; RHESUS D ANTIBODY; RITUXIMAB;

ARTICLE; BLEEDING; CHILD; DISEASE SEVERITY; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MAJOR CLINICAL STUDY; MALE; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REFRACTORY THROMBOCYTOPENIA; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SCHOOL CHILD; SINGLE DRUG DOSE; SPLENECTOMY; SPRING; SUMMER; THROMBOCYTE COUNT; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84864396931     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2012.03606.x     Document Type: Article

References (23)

1. Cines DB, Blanchette VS,. Immune thrombocytopenic purpura. N. Engl. J. Med. 2002; 346: 995-1008.
2. Rodeghiero F, Stasi R, Gernsheimer T, et al,. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: Report from an international working group. Blood 2009; 113: 2386-93.
3. Segel GB, Feig SA,. Controversies in the diagnosis and management of childhood acute immune thrombocytopenic purpura. Pediatr. Blood Cancer 2009; 53: 318-24.
4. Kaplan RN, Bussel JB,. Differential diagnosis and management of thrombocytopenia in childhood. Pediatr. Clin. North Am. 2004; 51: 1109-140. (Pubitemid 38962686)
5. Black C, Kaye JA, Jick H,. MMR vaccine and idiopathic thrombocytopenic purpura. Br. J. Clin. Pharmacol. 2003; 55: 107-11. (Pubitemid 36110846)
6. Mantadakis E, Farmaki E, Buchanan GR,. Thrombocytopenic purpura after measles-mumps-rubella vaccination: A systematic review of the literature and guidance for management. J. Pediatr. 2010; 156: 623-28.
7. Provan D, Stasi R, Newland AC, et al,. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010; 115: 168-86.
8. Blanchette VS, Carcao M,. Childhood acute immune thrombocytopenic purpura: 20 years later. Semin. Thromb. Hemost. 2003; 29: 605-17. (Pubitemid 38041412)
9. George JN, Woolf SH, Raskob GE, et al,. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88: 3-40. (Pubitemid 26230668)
10. Imbach P, Kühne T, Müller D, et al,. Childhood ITP: 12 months follow-up data from the prospective Registry I of the Intercontinental Childhood ITP Study Group (ICIS). Pediatr. Blood Cancer 2006; 46: 351-56. (Pubitemid 43201852)
11. Provan D, Newland A, Norfolk D, for the Working Party of the British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br. J. Haematol. 2003; 120: 574-96.
12. Kühne T, Buchanan GR, Zimmerman S, et al,. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group. J. Pediatr. 2003; 143: 605-8. (Pubitemid 37452786)
13. Neunert CE, Buchanan GR, Imbach P, et al,. Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood 2008; 112: 4003-8.
14. Shirahata A, Fujisawa K, Ishii E, et al,. A nationwide survey of newly diagnosed childhood idiopathic thrombocytopenic purpura in Japan. J. Pediatr. Hematol. Oncol. 2009; 31: 27-32.
15. Arnold DM, Dentali F, Mark A, et al,. Systematic review: Efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann. Intern. Med. 2007; 146: 25-33. (Pubitemid 351650318)
16. Parodi E, Rivetti E, Amendola G, et al,. Long-term follow-up analysis after rituximab therapy in children with refractory symptomatic ITP: Identification of factors predictive of a sustained response. Br. J. Haematol. 2009; 144: 552-8.
17. Bennett CM, Rogers ZR, Kinnamon DD, Bussel JB, Mahoney DH, Abshire TC,. Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura. Blood 2006; 107: 2639-42.
18. Mueller BU, Bennett C, Feldman H, et al,. for the Pediatric Rituximab/ITP Study Group and the Glaser Pediatric Research Network. One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximab. Pediatr. Blood Cancer 2009; 52: 259-62.
19. Kalpatthi R, Bussel JB,. Diagnosis, pathophysiology and management of children with refractory immune thrombocytopenic purpura. Curr. Opin. Pediatr. 2008; 20: 8-16.
20. Mantadakis E, Danilatou V, Stiakaki E, Kalmanti M,. Rituximab for refractory Evans syndrome and other immune-mediated hematologic diseases. Am. J. Hematol. 2004; 77: 303-10. (Pubitemid 39430712)
21. Aronis S, Platokouki H, Avgeri M, Pergantou H, Keramidas D,. Retrospective evaluation of long-term efficacy and safety of splenectomy in chronic idiopathic thrombocytopenic purpura in children. Acta Paediatr. 2004; 93: 638-42. (Pubitemid 38570231)
22. Kühne T, Blanchette V, Buchanan GR, et al,. Intercontinental Childhood ITP Study Group. Splenectomy in children with idiopathic thrombocytopenic purpura: A prospective study of 134 children from the Intercontinental Childhood ITP Study Group. Pediatr. Blood Cancer 2007; 49: 829-34. (Pubitemid 47519522)
23. Vranou M, Pergantou H, Platokouki H, Kousiafes D, Avgeri M, Aronis S,. Recurrent immune thrombocytopenic purpura in childhood. Pediatrics 2008; 121: S122-3.